Jim Cramer Asks Why The World's Largest Healthcare Products Company Has 'An Ill-Advised Strategy'

On CNBC’s "Mad Money Lightning Round," Jim Cramer said The Clorox Company’s CLX recent quarter was "ok." He added, "I think that the hack is behind them. I think Linda Rendle is doing a very good job."

AGNC Investment Corp. AGNC has "been a dog so long," Cramer said, "It’s just been a value trap."

Cramer said Cisco Systems, Inc. CSCO is a buy. The company’s stock has gained around 11% year-to-date.

When asked about Johnson & Johnson JNJ, he said, "I wish the CEO would come out and explain to me why they have such an ill-advised strategy."

Don’t forget to check out our premarket coverage here

The "Mad Money" host said Ventas, Inc. VTR got recommended on Tuesday, and "I think that’s ok. But it’s only got a 4% yield. I think you need to get more vague in order to be able to be in that group."

Price Action: Shares of Ventas fell 1.1% to close at $43.78, while Johnson & Johnson lost 0.5% to $150.90 on Tuesday. Cisco fell 0.3% to settle at $53.13, while AGNC gained 1.4% to close at $8.46 during Tuesday’s session. Clorox shares climbed 2.7% to settle at $132.52 on Tuesday.

Now Read This: Gannett And 3 Other Stocks Under $4 Insiders Are Buying

Photo: Shutterstock